Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reifenberger

Showing results (431-440 of 562) with videos related to

Pageof 57
Sort By:
Acta Neuropathologica|January 29, 2011
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytomaGenevieve Schindler, David Capper, Jochen Meyer, et al.
Acta Neuropathologica|September 7, 2018
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastomaDamian Stichel, Azadeh Ebrahimi, David Reuss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratificationAndrey Korshunov, Marc Remke, Wiebke Werft, et al.
Acta Neuropathologica|June 26, 2009
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasChristian Hartmann, Jochen Meyer, Jörg Balss, et al.
Acta Neuropathologica Communications|May 3, 2025
Identification and characterization of tertiary lymphoid structures in brain metastasesSadaf S Mughal, Yvonne Reiss, Jörg Felsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN lociStefan Pfister, Marc Remke, Axel Benner, et al.
Brain Pathology (Zurich, Switzerland)|February 5, 2017
Cerebral amyloidoma is characterized by B-cell clonality and a stable clinical courseKatharina Heß, Jan Purrucker, Ute Hegenbart, et al.
European Journal of Cancer (Oxford, England : 1990)|December 30, 2023
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trialEmilie Le Rhun, Thierry Gorlia, Jörg Felsberg, et al.
The Lancet. Oncology|May 15, 2012
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trialWolfgang Wick, Michael Platten, Christoph Meisner, et al.
Neuropathology and Applied Neurobiology|July 23, 2020
Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnosticsJ K Petersen, H B Boldt, M D Sørensen, et al.
Pageof 57

Showing results (431-440 of 562) with videos related to

Sort By:
Pageof 57
Acta Neuropathologica|January 29, 2011
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytomaGenevieve Schindler, David Capper, Jochen Meyer, et al.
Acta Neuropathologica|September 7, 2018
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastomaDamian Stichel, Azadeh Ebrahimi, David Reuss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratificationAndrey Korshunov, Marc Remke, Wiebke Werft, et al.
Acta Neuropathologica|June 26, 2009
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasChristian Hartmann, Jochen Meyer, Jörg Balss, et al.
Acta Neuropathologica Communications|May 3, 2025
Identification and characterization of tertiary lymphoid structures in brain metastasesSadaf S Mughal, Yvonne Reiss, Jörg Felsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN lociStefan Pfister, Marc Remke, Axel Benner, et al.
Brain Pathology (Zurich, Switzerland)|February 5, 2017
Cerebral amyloidoma is characterized by B-cell clonality and a stable clinical courseKatharina Heß, Jan Purrucker, Ute Hegenbart, et al.
European Journal of Cancer (Oxford, England : 1990)|December 30, 2023
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trialEmilie Le Rhun, Thierry Gorlia, Jörg Felsberg, et al.
The Lancet. Oncology|May 15, 2012
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trialWolfgang Wick, Michael Platten, Christoph Meisner, et al.
Neuropathology and Applied Neurobiology|July 23, 2020
Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnosticsJ K Petersen, H B Boldt, M D Sørensen, et al.
Pageof 57